rTMS for chronic tinnitus: multicenter randomized sham-controlled trial (negative)
Record details
- Authors: Landgrebe M, et al.
- Journal / source: Brain Stimulation (2017)
- Design: Multicenter randomized sham-controlled trial; 1-Hz left temporal rTMS, 10 sessions; ISRCTN89848288
- Sample: 163 randomized (75 real / 78 sham)
- Primary endpoint: Tinnitus Questionnaire change, baseline → day 12
- Randomized: Yes · Sham/placebo-controlled: Yes · Independent of the manufacturer: Yes
What this research found
NEGATIVE: TQ change −0.5 (real) vs +0.5 (sham); adjusted difference −1.0 [95% CI −3.2, 1.2], p=0.36. Well tolerated; not superior to sham.
The largest multicenter rTMS tinnitus trial. Together with Folmer 2015 (positive), it defines the conflicting replication picture for rTMS.
Limitations and conflicts of interest
Short 10-session protocol; day-12 primary timepoint.
Funding / conflicts: Independent.
Primary sources
Used as evidence for
This is an original summary from the Tinnitus Evidence verified database, checked against the primary source — not a reproduction of the publisher's abstract.